A new drug application (NDA) has been submitted to the FDA for sunvozertinib in pretreated EGFR exon 20–positive advanced non ...

NextCure is going all in on its preclinical B7-H4-directed antibody-drug conjugate (ADC). | NextCure is going all in on its ...

Here's a great starter guide to a low-cholesterol diet with a sample meal plan. The post Low-cholesterol diet made simple: ...

POLK expression in neurons and report an important observation that POLK exhibits an age-dependent change in subcellular localization, from the nucleus in young tissue to the cytoplasm in old tissue.

Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...

An 81-year-old woman with a 2-day history of vomiting and abdominal distension attended our hospital. The patient reported no fever, recent travel abroad, or change of bowel habit. She had a 3-year ...

Broccoli has antimicrobial, anti-inflammatory, and possible anti-cancer benefits. Learn how to make broccoli taste yummy to ...

Tile scans were acquired using a voxel size of 0.332x0.332x1.200 µm, a pixel dwell of 2µs, and a 10% tile overlap. For 3D visualization, shift correction, object rendering, and cell tracking, ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.